enVVeno Medical (NVNO) Long-Term Debt Issuances (2017 - 2018)
enVVeno Medical (NVNO) recorded quarterly Long-Term Debt Issuances of $2.6 million in Q1 2018, down 50.77% quarter-over-quarter from $5.3 million in Q4 2017.
enVVeno Medical (NVNO) Long-Term Debt Issuances (2017 - 2018) Analysis & Trends
enVVeno Medical's Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $2.6 million for Q1 2018.
- In Q1 2018, Long-Term Debt Issuances changed N/A year-over-year to $2.6 million; the TTM figure through Dec 2018 stood at $2.6 million (changed N/A YoY), while the FY2020 annual figure was $312700.0, changed N/A from the prior year.
- Long-Term Debt Issuances was $2.6 million for Q1 2018 at enVVeno Medical, down from $5.3 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $5.3 million in Q4 2017 to a low of $2.6 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | enVVeno Medical | 6.86 Mn | 6.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 2.60 Mn |
| Mar 31, 2018 | 2.60 Mn |
| Dec 31, 2017 | 5.29 Mn |
| Dec 31, 2017 | 5.29 Mn |